-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Low-grade inflammation in young adults may contribute to the early development of cardiovascular disease
Blood vessel
A total of 3306 adolescents and young adults from the Avon Parent and Child Longitudinal Study (mean age, 15.
Hypertensive metabolic syndrome in children
Compared with CRP, GlycA showed a greater association at 9 to 10 years of follow-up, especially in the younger adolescent group (r=0.
In contrast, CRP levels appear to be primarily BMI-mediated, with little or no relationship to any measured cardiovascular risk factors or phenotype
CONCLUSIONS: Low-grade inflammation, as determined by the novel biomarker GlycA, is associated with an adverse cardiovascular risk profile in early adolescence and predicts future risk of hypertension and metabolic syndrome at up to 10 years of follow-
Low-grade inflammation, as identified by the novel biomarker GlycA, is associated with an adverse cardiovascular risk profile in early adolescence and predicts future risk of hypertension and metabolic syndrome at up to 10 years of follow-up
Original source:
Scott T.
